ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,086Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 262

$503K Total Retail Price of All Prescriptions

Rank: 20 out of 262

462 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,708 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 514 437 1 1
LEVOTHYROXINE SODIUM 493 393 2 2
OMEPRAZOLE 319 224 3 5
FUROSEMIDE 312 270 4 4
AMLODIPINE BESYLATE 307 278 5 6
LISINOPRIL 273 240 6 3
METOPROLOL TARTRATE 269 241 7 8
CITALOPRAM HBR 228 184 8 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 212 185 9 24
METFORMIN HCL 189 131 10 9
HYDROCODONE-ACETAMINOPHEN 184 82 S3 11 15
ALLOPURINOL 169 140 12 22
HYDROCHLOROTHIAZIDE 156 150 13 7
METOPROLOL SUCCINATE 147 135 14 11
GABAPENTIN 117 61 15 19
ALENDRONATE SODIUM 109 109 16 21
ATORVASTATIN CALCIUM 105 84 17 13
DONEPEZIL HCL 98 94 18 23
TRAZODONE HCL 96 67 19 36
CARVEDILOL 94 87 20 31
CLOPIDOGREL 89 84 21 38
WARFARIN SODIUM 88 83 22 12
CELEBREX 86 71 23 91
POTASSIUM CHLORIDE 86 84 23 10
ZOLPIDEM TARTRATE 85 64 25 26
NAMENDA 80 77 26 37
OXYBUTYNIN CHLORIDE 79 79 27 90
DIOVAN HCT 79 57 27 103
PREDNISONE 79 74 27 29
FLUOXETINE HCL 77 47 30 46
METOCLOPRAMIDE HCL 75 33 31 124
ATENOLOL 75 60 31 16
TRAMADOL HCL 73 45 33 18
AZITHROMYCIN 73 54 33 44
SPIRONOLACTONE 73 49 33 58
GLIPIZIDE XL 71 68 36 87
DIGOXIN 69 65 37 28
CARBIDOPA-LEVODOPA 67 56 38 66
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 62 39 93
TAMSULOSIN HCL 63 44 40 25
LOSARTAN-HYDROCHLOROTHIAZIDE 62 62 41 43
FLUTICASONE PROPIONATE 61 47 42 48
POLYETHYLENE GLYCOL 3350 61 35 42 42
RANITIDINE HCL 61 46 42 62
QUETIAPINE FUMARATE 59 27 45 71
CYCLOBENZAPRINE HCL 58 34 R 46 110
ADVAIR DISKUS 55 47 47 34
LOSARTAN POTASSIUM 54 38 48 17
BUPROPION HCL SR 51 20 49 219
DETROL LA 51 25 49 76
PRAVASTATIN SODIUM 51 51 49 41
SYMBICORT 51 42 49 174
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.